Suvretta Capital Management 13F annual report

Suvretta Capital Management is an investment fund managing more than $2.37 trillion ran by Glenn Shepard. There are currently 99 companies in Mr. Shepard’s portfolio. The largest investments include Biohaven Ltd and Kura Oncology Inc, together worth $370 billion.

$2.37 trillion Assets Under Management (AUM)

As of 8th May 2024, Suvretta Capital Management’s top holding is 4,003,046 shares of Biohaven Ltd currently worth over $219 billion and making up 9.2% of the portfolio value. Relative to the number of outstanding shares of Biohaven Ltd, Suvretta Capital Management owns more than approximately 0.1% of the company. In addition, the fund holds 7,069,627 shares of Kura Oncology Inc worth $151 billion, whose value grew 122.9% in the past six months. The third-largest holding is Arcellx Inc worth $109 billion and the next is Meta Platforms Inc worth $84.3 billion, with 173,605 shares owned.

Currently, Suvretta Capital Management's portfolio is worth at least $2.37 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Suvretta Capital Management

The Suvretta Capital Management office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Glenn Shepard serves as the Chief Financial Officer at Suvretta Capital Management.

Recent trades

In the most recent 13F filing, Suvretta Capital Management revealed that it had opened a new position in Coca-Cola Co and bought 546,500 shares worth $33.4 billion. This means they effectively own approximately 0.1% of the company. Coca-Cola Co makes up 100.0% of the fund's Consumer Staples sector allocation and has decreased its share price by 1.3% in the past year.

The investment fund also strengthened its position in Kura Oncology Inc by buying 123,397 additional shares. This makes their stake in Kura Oncology Inc total 7,069,627 shares worth $151 billion. Kura Oncology Inc soared 65.2% in the past year.

On the other hand, there are companies that Suvretta Capital Management is getting rid of from its portfolio. Suvretta Capital Management closed its position in Las Vegas Sands Corp on 15th May 2024. It sold the previously owned 738,163 shares for $36.3 billion. Glenn Shepard also disclosed a decreased stake in Biohaven Ltd by 0.1%. This leaves the value of the investment at $219 billion and 4,003,046 shares.

One of the largest hedge funds

The two most similar investment funds to Suvretta Capital Management are Parsec Management and Hennessy Advisors Inc. They manage $2.37 trillion and $2.37 trillion respectively.


Glenn Shepard investment strategy

Suvretta Capital Management’s portfolio is diversified across 10 sectors. Currently, their heaviest sector is Health Care — making up 51.3% of the total portfolio value. The fund focuses on investments in the United States as 64.6% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 46% of the total holdings value. On the other hand, small-cap stocks make up only 4.0% of the portfolio. The average market cap of the portfolio companies is close to $120 billion.

The complete list of Suvretta Capital Management trades based on 13F SEC filings

These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Biohaven Ltd
12.46%
4,003,046
$218,926,586,000 9.23%
Kura Oncology Inc
1.78%
7,069,627
$150,795,144,000 6.36%
Arcellx Inc
35.86%
1,562,354
$108,661,721,000 4.58%
Meta Platforms Inc
21.15%
173,605
$84,299,116,000 3.56%
Ultragenyx Pharmaceutical In
21.14%
1,676,811
$78,290,306,000 3.30%
Arcutis Biotherapeutics Inc
7.03%
7,877,297
$78,064,013,000 3.29%
EyePoint Pharmaceuticals Inc
7.22%
3,763,888
$77,799,565,000 3.28%
89bio Inc
28.83%
6,298,004
$73,308,767,000 3.09%
Royalty Pharma plc
42.12%
2,250,361
$68,343,464,000 2.88%
Intra-Cellular Therapies Inc
17.73%
959,198
$66,376,502,000 2.80%
Amazon.com Inc.
3.02%
356,962
$64,388,806,000 2.72%
Advanced Micro Devices Inc.
2.47%
341,699
$61,673,253,000 2.60%
Insmed Inc
24.64%
2,023,000
$54,883,990,000 2.32%
Cigna Group (The)
42.41%
137,139
$49,807,513,000 2.10%
KalVista Pharmaceuticals Inc
56.18%
4,192,005
$49,717,179,000 2.10%
Verizon Communications Inc
64.53%
1,179,452
$49,489,806,000 2.09%
Argenx Se
127.00%
121,900
$47,994,468,000 2.02%
Marinus Pharmaceuticals Inc
4.44%
5,108,520
$46,181,021,000 1.95%
Goldman Sachs Group, Inc.
0.38%
109,890
$45,899,954,000 1.94%
Taiwan Semiconductor Mfg Ltd
15.17%
329,352
$44,808,340,000 1.89%
AT&T, Inc.
96.60%
2,398,619
$42,215,694,000 1.78%
Apollo Global Mgmt Inc
31.47%
370,636
$41,678,018,000 1.76%
Ferguson Plc New
3.87%
169,280
$36,975,830,000 1.56%
General Electric Co
41.76%
207,447
$36,413,172,000 1.54%
Las Vegas Sands Corp
Closed
738,163
$36,325,001,000
Coca-Cola Co
Opened
546,500
$33,434,870,000 1.41%
Microsoft Corporation
51.02%
79,317
$33,370,248,000 1.41%
Sutro Biopharma Inc
No change
5,778,188
$32,646,762,000 1.38%
Mckesson Corporation
10.75%
56,639
$30,406,647,000 1.28%
Apple Inc
Opened
176,680
$30,297,086,000 1.28%
CRH Plc
Opened
335,580
$28,947,131,000 1.22%
Arrivent Biopharma Inc
Opened
1,563,709
$27,927,843,000 1.18%
Fulcrum Therapeutics Inc
48.39%
2,848,486
$26,889,708,000 1.13%
Elevance Health Inc
5.23%
50,925
$26,406,650,000 1.11%
Oracle Corp.
38.93%
196,674
$24,704,221,000 1.04%
Chipotle Mexican Grill
8.50%
7,970
$23,166,957,000 0.98%
Bicycle Therapeutics plc
No change
914,476
$22,770,452,000 0.96%
Pepgen Inc
212.56%
1,520,932
$22,357,700,000 0.94%
Boston Scientific Corp.
56.34%
303,035
$20,754,867,000 0.88%
Fate Therapeutics Inc
Opened
2,562,852
$18,811,334,000 0.79%
Arcus Biosciences Inc
No change
957,304
$18,073,900,000 0.76%
Hilton Worldwide Holdings Inc
28.15%
78,502
$16,745,262,000 0.71%
Salesforce Inc
Opened
55,050
$16,579,959,000 0.70%
Starbucks Corp.
Opened
172,951
$15,805,992,000 0.67%
Johnson & Johnson
No change
90,097
$14,252,444,000 0.60%
Global Pmts Inc
5.59%
106,094
$14,180,524,000 0.60%
Pinterest Inc
Opened
395,851
$13,724,154,000 0.58%
Mereo BioPharma Group plc
50.43%
3,653,494
$12,056,530,000 0.51%
Sanofi
23.22%
210,701
$10,240,069,000 0.43%
Immatics N.v
Opened
946,563
$9,948,377,000 0.42%
Terns Pharmaceuticals Inc
76.64%
1,363,675
$8,945,708,000 0.38%
Agios Pharmaceuticals Inc
Closed
399,451
$8,895,774,000
Inflarx Nv
No change
5,733,910
$8,830,221,000 0.37%
Elanco Animal Health Inc
17.43%
507,200
$8,257,216,000 0.35%
Revance Therapeutics Inc
Opened
1,600,000
$7,872,000,000 0.33%
AnaptysBio Inc
Closed
354,872
$7,601,358,000
Unitedhealth Group Inc
17.94%
15,123
$7,481,348,000 0.32%
Zura Bio Ltd
No change
2,850,000
$7,324,500,000 0.31%
Ge Healthcare Technologies I
Opened
75,000
$6,818,250,000 0.29%
Korro Bio Inc
No change
73,821
$6,643,890,000 0.28%
Sana Biotechnology Inc
Closed
1,606,056
$6,552,708,000
Kezar Life Sciences Inc
No change
7,167,591
$6,462,300,000 0.27%
Prokidney Corp
No change
3,867,847
$6,343,269,000 0.27%
Spyre Therapeutics Inc
No change
162,395
$6,159,642,000 0.26%
Alnylam Pharmaceuticals Inc
231.24%
32,660
$4,881,037,000 0.21%
Astrazeneca plc
Closed
70,490
$4,747,502,000
Thermo Fisher Scientific Inc.
No change
7,260
$4,219,585,000 0.18%
Danaher Corp.
No change
16,427
$4,102,150,000 0.17%
Abbott Labs
No change
33,520
$3,809,883,000 0.16%
Teva Pharmaceutical Inds Ltd
46.10%
268,100
$3,782,891,000 0.16%
Gilead Sciences, Inc.
123.35%
50,700
$3,713,775,000 0.16%
Kenvue Inc
No change
171,596
$3,682,450,000 0.16%
Cencora Inc.
No change
12,488
$3,034,459,000 0.13%
Tourmaline Bio Inc
Opened
125,000
$2,862,500,000 0.12%
Mettler-Toledo International, Inc.
Opened
1,964
$2,614,654,000 0.11%
Incyte Corp.
Closed
37,600
$2,360,904,000
Natera Inc
No change
24,600
$2,249,916,000 0.09%
Cogent Biosciences, Inc.
91.48%
316,000
$2,123,520,000 0.09%
Intuitive Surgical Inc
69.38%
5,200
$2,075,268,000 0.09%
Avantor, Inc.
87.84%
71,850
$1,837,205,000 0.08%
IQVIA Holdings Inc
No change
7,175
$1,814,486,000 0.08%
Merck & Co Inc
Closed
15,500
$1,689,810,000
Molecular Partners Ag
No change
400,000
$1,680,000,000 0.07%
Stryker Corp.
No change
4,360
$1,560,313,000 0.07%
Medtronic Plc
No change
17,460
$1,521,639,000 0.06%
Galapagos NV
No change
47,200
$1,519,840,000 0.06%
Pfizer Inc.
Closed
50,300
$1,448,137,000
CVS Health Corp
No change
17,170
$1,369,479,000 0.06%
Illumina Inc
No change
8,730
$1,198,804,000 0.05%
Akili Inc
No change
3,841,718
$1,112,562,000 0.05%
Waters Corp.
No change
3,150
$1,084,325,000 0.05%
Benitec Biopharma Inc
No change
204,220
$1,072,155,000 0.05%
HCA Healthcare Inc
Opened
3,190
$1,063,961,000 0.04%
Edwards Lifesciences Corp
Opened
11,100
$1,060,716,000 0.04%
Protagonist Therapeutics Inc
Opened
30,500
$882,365,000 0.04%
Dexcom Inc
No change
5,880
$815,556,000 0.03%
Agilent Technologies Inc.
No change
4,990
$726,095,000 0.03%
Morgan Stanley
59.19%
7,641
$719,477,000 0.03%
Humana Inc.
Opened
1,950
$676,104,000 0.03%
Idexx Labs Inc
Closed
920
$510,646,000
Veralto Corp
No change
5,475
$485,414,000 0.02%
Resmed Inc.
Opened
2,390
$473,292,000 0.02%
Ionis Pharmaceuticals Inc
Opened
10,800
$468,180,000 0.02%
Zimmer Biomet Holdings Inc
Opened
3,260
$430,255,000 0.02%
Align Technology, Inc.
Opened
1,100
$360,712,000 0.02%
Steris Plc
Opened
1,530
$343,975,000 0.01%
Baxter International Inc.
Opened
7,970
$340,638,000 0.01%
United Therapeutics Corp
Closed
1,360
$299,050,000
Charles Riv Labs Intl Inc
No change
1,010
$273,660,000 0.01%
Bio-Techne Corp
Closed
2,600
$200,616,000
No transactions found
Showing first 500 out of 110 holdings